NSN 6505-01-512-8629
Part Details | PROMETHAZINE HYDROCHLORIDE INJECTION
6505-01-512-8629
Alternate Parts: 031800, 03-1800, NDC00703219104, NDC00703-2191-04, 6505-01-512-8629, 01-512-8629, 6505015128629, 015128629
Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
---|---|---|---|
65 | SEP 11, 2003 | 01-512-8629 | 09404 ( PROMETHAZINE HYDROCHLORIDE INJECTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-512-8629
Part Number | Cage Code | Manufacturer |
---|---|---|
03-1800 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
NDC00703-2191-04 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. |
Technical Data | NSN 6505-01-512-8629
Characteristic | Specifications |
---|---|
PRIMARY CONTAINER CONTENT QUANTITY | 1.000 MILLILITERS |
PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
ACTIVE MEDICAMENT MEDICINAL STRENGTH | BY25.000 MILLIGRAMS PROMETHAZINE HYDROCHLORIDE |
PHARMACEUTICAL VEHICLE TYPE | B ANY ACCEPTABLE |
ADMINISTRATION | INTRAMUSCULAR AND INTRAVENOUS |
TOTAL PRIMARY CONTAINER QUANTITY | 25 |
FEATURES PROVIDED | STERILE |
SPECIAL FEATURES | LIGHT SENSITIVE, PROTECT FROM LIGHT, KEEP COVERED IN CARTON UNTIL TIME OF USE; STORE AT CONTROLLED ROOM TEMP 20 TO 25 DEG C; FOR CONTROL OF NAUSEA AND VOMITING AND TO PROVIDE SEDATION AND RELIEVE APPREHENSION IN THE EARLY STAGES OF LABOR; NOT RECOMMENDED FOR USE IN PEDIATRIC PATIENTS LESS THAN TWO YEARS OF AGE; 25 DOSETTE VIALS |
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 040000 |
PART NAME ASSIGNED BY CONTROLLING AGENCY | PHENERGAN PROMETHAZINE HCI INJECTION USP 25MG/ML 1ML DOSETTE VIAL 25S |